Pfizer

Pfizer studied a lower dose of its vaccine in more than 2,200 kindergartners and elementary school-aged kids. They developed coronavirus-fighting antibody levels as strong as teens and young adults.

Now that the Food and Drug Administration has fully approved the Pfizer-BioNTech vaccine against COVID-19, South Florida health care experts hope to see more vaccine mandates and more people getting their shots.

The approval replaces the emergency use authorizations granted last December and could make it easier for employers, the military and universities to mandate vaccination.

Vivek Murthy no decision had been made after a meeting Monday with Pfizer to discuss its request for approval of a third shot of its coronavirus vaccine.

The clock is ticking for parents to get their kids shots if they want them fully vaccinated by the first day of class. Schools are trying to make it easier for families.

Parents or guardians need to accompany kids to the vaccination.

Ages 12 and older are now eligible to be vaccinated against COVID-19, the FDA and the CDC say. But when and where, and what about younger kids? You have questions. We have answers.

Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.

Pfizer plans to submit emergency-use authorization requests in September, with one covering children 2 to 5 years old and a second applying to ages 5 to 11.

FDA action could lead to the two-dose shots being available for younger teens before the beginning of the next school year.

The researchers confirmed all of the patients were infected with COVID-19 with five suffering severe symptoms that required hospitalization.

Allergists say the risks associated with COVID-19 are far greater than the risks associated with vaccines.